Related content

Arthritis and bursitis in multiple sclerosis patients treated with interferon‐beta

By Strueby L.   Nair B.   Kirk A.   Taylor R. M.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 6, 2005-11 ,pp. : 485-488

Informa Healthcare

Access to resources Recommend Favorite

Interleukin‐1β influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis

By Kopp S.   Alstergren P.   Ernestam S.   Nordahl S.   Bratt J.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 3, 2006-05 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite

Radiological progression of joint damage in a longitudinal cohort of early DMARD-treated rheumatoid arthritis patients followed for 10 years

By Wick MC   Anderwald C   Weiss RJ   Imhof H   Kainberger F   Smolen JS  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 3, 2004-05 ,pp. : 162-166

Informa Healthcare

Access to resources Recommend Favorite

Disability and health‐related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain, and depressive symptoms

By Rupp I.   Boshuizen H. C.   Dinant H. J.   Jacobi C. E.   van den Bos G. A. M.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 3, 2006-05 ,pp. : 175-181

Informa Healthcare

Access to resources Recommend Favorite

No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan

By Nakajima Ayako   Saito Kazuyoshi   Kojima Toshihisa   Amano Koichi   Yoshio Taku   Fukuda Wataru   Inoue Eisuke   Taniguchi Atsuo   Momohara Shigeki   Minota Seiji   Takeuchi Tsutomu   Ishiguro Naoki   Tanaka Yoshiya   Yamanaka Hisashi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 945-952

Springer Publishing Company

Access to resources Recommend Favorite